12 lead ecg information from trusted sources:
SAVELLA
Milnacipran hydrochloride is a selective norepinephrine and serotonin reuptake inhibitor, it inhibits norepinephrine uptake with greater potency than serotonin. It is a racemic mixture with the chemical name: (&plusmn,)-[1R(S),2S(R)]-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide hydrochloride. The structural formula is:Milnacipran hydrochloride is a white to off-white crystalline powder with a melting point of 179°C. Savella is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the management of fibromyalgia (1) 2 DOSAGE AND ADMINISTRATION 2.1 Recommended Dosing 2.2 Patients with Renal Insufficiency 2.3 Patients with Hepatic Insufficiency 2.4 Discontinuing Savella 2.5 Switching patients to or from a Monoamine Oxidase Inhibitor (MAOI) 3 DOSAGE FORMS AND STRENGTHS 4 CONTRAINDICATIONS 4.1 Monoamine Oxidase Inhibitors 4.2 Uncontrolled Narrow-Angle Glaucoma 5 WARNINGS AND PRECAUTIONS 5.1 Suicide Risk 5.2 Serotonin Syndrome 5.3 Effects on Blood Pressure 5.4 Effects on Heart Rate 5.5 Seizures 5.6 Hepatotoxicity 5.7 Discontinuation of Treatment with Savella 5.8 Hyponatremia 5.9 Abnormal Bleeding 5.10 Activation of Mania 5.11 Patients with a History of Dysuria 5.12 Controlled Narrow-Angle Glaucoma 5.13 Concomitant Use with Alcohol 5.14 Allergy to FD&C Yellow No. 5 6 ADVERSE REACTIONS 6.1 Clinical Trial Data Sources 6.2 Adverse Reactions Leading to Discontinuation 6.3 Most Common Adverse Reactions 6.4 Weight Changes 6.5 Genitourinary Adverse Reactions in Males 6.6 Other Adverse Reactions Observed During Clinical Trials of Savella in Fibromyalgia 6.7 Postmarketing Spontaneous Reports 7 DRUG INTERACTIONS 8 USE IN SPECIFIC POPULATIONS 8.1 Pregnancy 8.2 Labor and Delivery 8.3 Nursing Mothers 8.4 Pediatric Use 8.5 Geriatric Use 9 DRUG ABUSE AND DEPENDENCE 9.1 Controlled Substance 9.2 Abuse 9.3 Dependence 10 OVERDOSAGE 11 DESCRIPTION 12 CLINICAL PHARMACOLOGY 12.1 Mechanism of Action 12.2 Pharmacodynamics 12.3 Pharmacokinetics...
Celiac Sprue
Celiac sprue, also known as celiac disease, gluten-sensitive enteropathy, and gluten-induced enteropathy, is a chronic disease of the digestive tract that interferes with the digestion and absorption of nutrients from food. People with celiac sprue cannot tolerate gluten, a protein commonly found in wheat, rye, barley, and to some degree, oats. When affected individuals ingest foods containing gluten, the lining (mucosa) of the intestine becomes damaged due to the body's immune reaction. Because the lining of the intestine contains essential enzymes for digestion and absorption, its destruction leads to malabsorption, a difficulty in absorption of food and essential nutrients. As result, celiac sprue is often considered a malabsorption disorder. Persons with celiac sprue experience improvement in the condition when on a strict, gluten-free diet and relapse when dietary gluten is reintroduced. With treatment, celiac sprue is rarely fatal. However, untreated and unrecognized celiac disease may slightly increase the risk of developing intestinal lymphoma, a form of cancer. Celiac sprue is a genetic disease, the genes for this condition may be transmitted to some family members and not to others. Sometimes the disease is triggered, or becomes apparent for the first time, after surgery, pregnancy, childbirth, viral infection, or severe emotional stress. Celiac sprue is rare in persons with an African American, Caribbean, or Asian background. Females are slightly more affected than males. Although celiac sprue can manifest at any age, the detection of this disease usually peaks at 8-12 months and in the third to fourth decade of life. The true prevalence of celiac sprue is not known. The increased awareness and the availability of better diagnostic tests have led to the realization that the disease is relatively common. The highest prevalence is in Western Europe and in places where Europeans emigrated, notably North America and Australia. In these regions, celiac sprue affects approximately 1 of every 250-300 individuals. In the United States, the estimated prevalence is 1 case per 3,000 in the population. However, this rate is likely an underestimation, a recent study involving 2,000 healthy blood donors showed an estimated prevalence of 1 case in 300.
Prehospital 12-lead ECG-Is it Useful Technology and How Do We Get ...
File Format: PDF/Adobe Acrobat
Usefulness of automated serial 12-lead ECG monitoring during the ...
by FM Fesmire - 1998 - Cited by 103 - Related articles
Pins and needles
Leading a healthy lifestyle can reduce the risk of developing a condition responsible for causing chronic pins and needles. This includes...
Conivaptan Conjunctival
The most common adverse reactions reported with VAPRISOL administration were infusion site reactions. In studies in patients and healthy volunteers, infusion site reactions occurred in 52.5% of subjects treated with VAPRISOL 40 mg/day compared to 3.3% in the placebo group. The majority of the reactions were mild and did not lead to discontinuation of drug. However, some serious infusion site reactions did occur, and infusion site reactions were the most common type of adverse event leading to...
Out-of-Hospital 12-Lead ECG
Considerations for implementation of out-of-hospital 12-lead ECG programs should include local factors, such as EMS vehicle staffing, response and transport ...
Pediatric Dysrhythmias: 12-Lead ECG Interpretation
Pediatric Dysrhythmias: 12-Lead ECG Interpretation. (This CE activity is for physicians only). Leanna Miller, RN, MN, CCRN, CMC, PCCN, CEN, NP ...
Accuracy of advanced versus strictly conventional 12-lead ECG for ...
File Format: PDF/Adobe Acrobat - Quick View